BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Opioid Overdose Victims Confront Purdue Pharma’s Sackler Family Following Latest Settlement

  More than two dozen people were given the opportunity to confront members of the Sackler family in a virtual environment and share the impactful pain opioid addiction caused their families.

  March 11, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Sanofi Unites Under a Single Purpose at Cambridge Crossing

  Cambridge Crossing will enable innovative drug discovery platforms for chemistry, protein engineering, structural and synthetic biology, among other key modalities.

  March 11, 2022

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Business

  Harpoon to Discontinue Once Promising Treatment for Prostate Cancer

  Harpoon Therapeutics, Inc. has unfortunately announced that it will move to discontinue one of its promising T cell engager biologics, HPN424.

  March 11, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Research Roundup: Genetic Variants Associated with Severe COVID-19 and More

  Researchers have now identified 16 new genetic variants associated with severe COVID-19. For that and more research stories, continue reading.

  March 11, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Capricor Ditches COVID-19 Vaccine Program to Focus on DMD

  Capricor Therapeutics announced less-than-stellar Q4 2021 and full-year 2021 financial results and said the company stopped efforts on its COVID-19 vaccine.

  March 11, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Policy

  Report: COVID-19 Death Toll Could Top 18 Million, Deltacron Rears

  The death toll related to COVID-19 is more than 6 million, according to the Johns Hopkins COVID-19 dashboard, but it has long been suspected that the toll is significantly higher.

  March 11, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  More Unique Therapeutic Possibilities Posed by Rare Human Genes

  The discovery of a unique, inheritable resistance to Ebola infection has inspired the development of therapeutics that may not only be effective against Ebola but against COVID-19, as well.

  March 11, 2022

   · 

  5 min read

   · 

  Kaylei Whalen
• 

  Policy

  Russian Invasion Hampers COVID-19 Vaccine Effort in Ukraine

  The Russian invasion of Ukraine has hampered Ukrainian research to develop new treatments for infection from the SARS-CoV-2 virus and increased the risk of spreading virulent pathogens.

  March 11, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  On the Brink, Orphazyme Announces Second Round of Layoffs

  The Orphazyme board of directors decided to cut 50% of its current global staff count after carefully considering its financial state.

  March 11, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Selecta Revives MMA Gene Therapy Program After FDA Lifts Hold

  Selecta Biosciences is moving forward with development efforts for its gene therapy program for methylmalonic acidemia after the FDA lifted the hold on its clinical trial on March 9.

  March 11, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN